This topic contains a solution. Click here to go to the answer

Author Question: Most air-cooled equipment manufactured today is designed to operate with a: A) 120F condenser at ... (Read 139 times)

Wadzanai

  • Hero Member
  • *****
  • Posts: 528
Most air-cooled equipment manufactured today is designed to operate with a:
 
  A) 120F condenser at 95F B) 110F condenser at 95F.
  C) 115F condenser at 95F. D) 105F condenser at 95F.

Question 2

The motor starter is switched on and off by the:
 
  A) Contactors that are switched on and off by the motor relays.
  B) Control relays that are switched on and off by contactors.
  C) Motor relays that are switched on and off by the control relays.
  D) Contactors that are switched on and off by the control relays.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

onowka

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

C

Answer to Question 2

C




onowka

  • Sr. Member
  • ****
  • Posts: 353

 

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library